Certis USA today announced a brand change to Certis Biologicals. The new brand acknowledges the importance of biological-based crop inputs to farmers around the globe and cements the company’s legacy as manufacturer, supplier, and innovator of biological crop protection solutions.
“Certis is the most integrated, full-line provider of biological-based inputs in the agriculture industry,” said Amy O’Shea, President, and Chief Executive Officer. “Our name needs to reflect our global outlook as well as our wide range of products.”
History
Certis USA was established in 2001 after Mitsui & Co. acquired Thermo Trilogy. Certis’ legacy companies date back to the 1990s when W.R. Grace pioneered the use of neem technology to create Trilogy, one of the early EPA registrations for neem-based biopesticides.
“At Mitsui & Co., we strongly believe biologicals are an important part in the global food supply chain,” said Hitoshi Kudo, General Manager, Mitsui & Co. AgriScience division. “As the leading manufacturer of biological-based agriculture inputs, Certis is poised to innovate and provide biological-based solutions for growers for years to come.”
“Certis is the name that is synonymous with biologicals in agriculture,” O’Shea said of the new brand. “Our customers and channel partners trust us to deliver the proven biological solutions they need, whether they are in the US or across the globe, and our new brand, Certis Biologicals, ensures that our focus is clear.”
Partnership
Recently, through a partnership with OmniLytics, Certis continued its dedication to innovation with the introduction of bacteriophage technology to combat plant diseases, such as Fire Blight, Citrus Canker, and Tomato Speck and Spot along with providing an effective tool for resistance management. In the 2020 market year, Certis Biologicals launched Homeplate, an OMRI-Listed biological herbicide, BoteGHA an OMRI-Listed bioinsecticide, and received OMRI-Listing for OSO biofungicide. This level of continued portfolio growth signals that their dedication to offering innovative biotechnologies in agriculture will remain a top priority.
“There is much to be celebrated at Certis Biologicals,” said Mike Allan, Vice-President, North America. “This year, we celebrate with everyone who has made our growth and the growth of the entire marketplace possible and to look together toward a future where bio-based solutions allow us to better feed the world and protect the health of our environment.”
Certis Biologicals